Rafferty Asset Management’s Stoke Therapeutics STOK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $584K | Sell |
51,458
-10,248
| -17% | -$116K | ﹤0.01% | 853 |
|
|
2025
Q1 | $410K | Sell |
61,706
-5,521
| -8% | -$36.7K | ﹤0.01% | 908 |
|
|
2024
Q4 | $742K | Sell |
67,227
-15,561
| -19% | -$172K | ﹤0.01% | 840 |
|
|
2024
Q3 | $1.02M | Buy |
82,788
+2,903
| +4% | +$35.7K | ﹤0.01% | 796 |
|
|
2024
Q2 | $1.08M | Buy |
+79,885
| New | +$1.08M | ﹤0.01% | 806 |
|
|
2023
Q1 | – | Sell |
-14,429
| Closed | -$133K | – | 1165 |
|
|
2022
Q4 | $133K | Buy |
14,429
+3,382
| +31% | +$31.2K | ﹤0.01% | 1099 |
|
|
2022
Q3 | $142K | Buy |
+11,047
| New | +$142K | ﹤0.01% | 1110 |
|
|
2022
Q2 | – | Sell |
-62,065
| Closed | -$1.31M | – | 1219 |
|
|
2022
Q1 | $1.31M | Buy |
62,065
+15,624
| +34% | +$329K | 0.01% | 727 |
|
|
2021
Q4 | $1.11M | Buy |
46,441
+13,926
| +43% | +$334K | 0.01% | 821 |
|
|
2021
Q3 | $827K | Sell |
32,515
-278
| -0.8% | -$7.07K | 0.01% | 913 |
|
|
2021
Q2 | $1.1M | Sell |
32,793
-2,027
| -6% | -$68.2K | 0.01% | 847 |
|
|
2021
Q1 | $1.35M | Buy |
+34,820
| New | +$1.35M | 0.01% | 703 |
|